These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Siegert W; Agthe A; Griesser H; Schwerdtfeger R; Brittinger G; Engelhard M; Kuse R; Tiemann M; Lennert K; Huhn D Ann Intern Med; 1992 Sep; 117(5):364-70. PubMed ID: 1380221 [TBL] [Abstract][Full Text] [Related]
14. Angioimmunoblastic T cell lymphoma: an unusual presentation of posttransplant lymphoproliferative disorder in a pediatric patient. Kraus TS; Twist CJ; Tan BT Acta Haematol; 2014; 131(2):95-101. PubMed ID: 24157860 [TBL] [Abstract][Full Text] [Related]
15. [Angio-immunoblastic lymphadenopathy: analysis of 70 cases]. Liu XL; Su NS; Chen YH Zhonghua Nei Ke Za Zhi; 1985 Aug; 24(8):472-5, 510. PubMed ID: 4053811 [No Abstract] [Full Text] [Related]
16. [Immunoblastic lymphadenopathy-like T cell lymphoma associated with erythroid hypoplasia and thrombocytopenia]. Shirakawa C; Enomoto H; Tanaka H; Yonekawa S; Irimajiri K; Horiuchi A Rinsho Ketsueki; 1996 Aug; 37(8):701-6. PubMed ID: 8827881 [TBL] [Abstract][Full Text] [Related]
17. [Angioimmunoblastic T-cell lymphoma with marked polyclonal plasmacytosis in peripheral blood and bone marrow mimicking plasma cell leukemia]. Mitsuhashi K; Shiseki M; Ishiyama M; Kondo T; Kazama H; Yasunami T; Okamura T; Yoshinaga K; Mori N; Teramura M; Masuda A; Motoji T Rinsho Ketsueki; 2011 Jul; 52(7):563-9. PubMed ID: 21821991 [TBL] [Abstract][Full Text] [Related]
18. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient. Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851 [No Abstract] [Full Text] [Related]
19. Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient. Ishii Y; Itabashi M; Numata A; Yamamoto W; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S Intern Med; 2016; 55(6):673-5. PubMed ID: 26984089 [TBL] [Abstract][Full Text] [Related]